
|Articles|May 1, 2019 (Updated: November 15, 2020)
- Pharmaceutical Executive-05-01-2019
- Volume 39
- Issue 5
Pharmaceutical Executive, May 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Impact Investing and R&Dalmost 7 years ago
New Flare-Up in Europe's External Reference Pricing Debatealmost 7 years ago
It’s Time for a Chief Adherence Officeralmost 7 years ago
Adopting New Technology: Barriers and Breakthroughsalmost 7 years ago
The CFO Evolutionalmost 7 years ago
We’ve Got You Coveredalmost 7 years ago
Survey Spotlights the CFO’s Strategic Risealmost 7 years ago
FDA After Gottlieb: Thorny Issues, Political Challengesalmost 7 years ago
Easing the Path to Profitabilityalmost 7 years ago
A Strategic Approach to Pharma R&D Portfolio PlanningNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
4
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
5




